Effect of oral administration of Butyrivibrio fibrisolvens MDT-1, a gastrointestinal bacterium, on 3-methylcholanthrene-induced tumor in mice.
Butyrivibrio fibrisolvens MDT-1 was evaluated for use as a probiotic to prevent tumor formation. Oral administration of MDT-1 (10(9) cfu/dose, 3 times a wk for 15 wk) delayed the onset of tumors induced by 3-methylcholanthrene and also reduced tumor incidence in mice. Furthermore, the numbers of natural killer (NK) and NKT cells in the spleen increased markedly in response to MDT-1 administration. Increased numbers of NK and NKT cells may contribute to the alleviation of carcinogenesis by MDT-1 administration. Cultured splenic lymphocytes isolated from mice fed MDT-1 produced higher levels of interferon-gamma than control mice but showed no change in interleukin-4 production. These results suggest that MDT-1 administration skews the ratio of helper T (Th) cells type 1 (Th1) to Th2 toward Th1 dominance. MDT-1 administration resulted in increased immunoglobulin A secretion into the intestine. These results suggest that probiotic B. fibrisolvens MDT-1 may contribute to the prevention or alleviation of cancers, allergic disorders, and infectious diseases.